Marker for assessing quality of ivm-derived embryos and use thereof
By identifying and recording specific morphodynamic parameters of IVM embryos, an image data evaluation method was established, which solved the problem of insufficient accuracy in IVM embryo evaluation, improved the prediction of blastocyst formation and chromosome euploidy, and enhanced the effectiveness of assisted reproductive technology.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
- Filing Date
- 2026-03-12
- Publication Date
- 2026-06-26
AI Technical Summary
In existing technologies, the morphodynamic characteristics of IVM-derived embryos lack uniformity and standardization, resulting in insufficient assessment accuracy and affecting the outcome of assisted reproductive technologies.
By labeling and recording the morphodynamic parameters t2, t9, S2, t9–t7, t9–t8, or tSB–t9 of IVM-derived embryos, the relationship between these parameters and embryo blastocyst formation and chromosome euploidy was identified, a specific assessment method was established, and in vitro assessment was performed using image data.
It provides more accurate quality assessment of IVM-derived embryos, improves the predictive ability of blastocyst formation potential and chromosome euploidy, and improves the clinical outcomes of assisted reproductive technologies.
Smart Images
Figure CN122290992A_ABST